Fenne’s case study focuses on Non-Steroidal Anti Inflammatory medication (NSAIDs) and looks for ways to improve without the drugs. Fenne is 21 years old and has been on the Paddison Program for rheumatoid arthritis for 3 months now and is happy for her update to be shared. Her story is an example of non NSAID pain relief.
Fenne was diagnosed with peripheral ankylosing spondylitis and psoriasis. She had treatment of corticosteroid injection to her knees for the swelling and Clint Paddison also discusses how these can be helpful. Fenne also tried numerous NSAID’s but her symptoms got worse.
Fenne’s doctor then suggested Methotrexate but Fenne was reluctant to take this. Clint stresses that he is not against medication but instead is pro-health to enable people to keep inflammation as low as possible (and medication can be a way to achieve this).
However, there are other people who also look for non-NSAID pain relief options. We discuss this in another podcast that features someone else, from the UK, who has been on the Paddison Program.
People are looking for non-NSAID pain relief because there are those who realise that potential negative impact the drugs can have on the gut’s microbiome [1].
Improving on the Paddison Program with Non NSAID Pain Relief Options
Fenne decided to try the Paddison program, and after four days she began to notice improvements. Her energy started to improve and she began to feel a little less pain. Redness reduced and the pain in her finger also began to improve.
She has reduced her medication in half, which is outstanding and is able to ride her electric bike for an hour which is a great pain relief for her. Clint talks about the need for safe exercise and stretches for the knees to reduce inflammation.
It is still early days for Fenne, yet she is now feeling happier and is focusing on healing.
Thank you to Fenne for sharing her story with us.
[1] Wang X, Tang Q, Hou H, Zhang W, Li M, Chen D, Gu Y, Wang B, Hou J, Liu Y, Cao H. Gut Microbiota in NSAID Enteropathy: New Insights From Inside. Front Cell Infect Microbiol. 2021 Jul 6;11:679396. doi: 10.3389/fcimb.2021.679396. PMID: 34295835; PMCID: PMC8290187.